From the update it looks like we should now assume an average dilution width to 0.7ms rather than 1m for narrower veins.
That means that for those narrower veins, the head grade will be roughly 30% better than if they were diluted to 1m.
We have another reason to expect head grades may reconcile higher than 10g/t and this one is far less debateable.
- Forums
- ASX - By Stock
- PRX
- ann: trial mining update
ann: trial mining update, page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $4.235M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $150 | 75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 15798362 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 23473387 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 15698362 | 0.002 |
23 | 90251099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 23473387 | 24 |
0.004 | 6609219 | 11 |
0.005 | 4688264 | 10 |
0.006 | 2600001 | 4 |
0.007 | 600000 | 2 |
Last trade - 11.02am 15/07/2024 (20 minute delay) ? |
Featured News
PRX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online